Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-037394
Filing Date
2017-10-23
Accepted
2017-10-23 09:49:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 49606
  Complete submission text file 0000000000-17-037394.txt   69305
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filed for) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations